Fagron NV Reports Ownership Restructure by AOC Pharma
Company Announcements

Fagron NV Reports Ownership Restructure by AOC Pharma

Fagron SA (GB:0HNZ) has released an update.

Fagron NV, a Belgian pharmaceutical company, announced that AOC Pharma S.à r.l. now indirectly controls 11.06% of its voting rights without crossing a notification threshold. The change came after a restructuring in the chain of control within AOC Pharma, with Active Ownership Fund SICAV-FIS SCS managing the voting rights and ultimately controlled by Active Ownership Group Ltd. Fagron, listed on Euronext Brussels and Amsterdam, specializes in pharmaceutical compounding and operates in over 30 countries.

For further insights into GB:0HNZ stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks European Auto-Generated NewsdeskFagron SA Achieves Strong Growth and Expands Globally
TipRanks European Auto-Generated NewsdeskFagron Completes Multimillion-Euro Share Buyback
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App